Opus Genetics Inc. has granted an equity award to a new non-executive employee in the form of options to purchase 50,000 shares of the company's common stock. The options have an exercise price equal to the fair market value on the grant date and will vest over four years, with 25% vesting after one year and the remaining 75% vesting in quarterly installments thereafter.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Opus Genetics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 9601702) on December 16, 2025, and is solely responsible for the information contained therein.
Comments